TMPRSS2 - inhibitors
(Meyer 2016 pmid: 23527573)
an aerosol formulation of aprotinin has been approved in Russia for local respiratory application in mildto-moderate influenza [22].
(Meyer 2016 pmid: 23527573)
an aerosol formulation of aprotinin has been approved in Russia for local respiratory application in mildto-moderate influenza [22].